Guillain–Barré Syndrome: An Autoimmune Attack on the Peripheral Nervous System A Review

Guillain-Barré Syndrome (GBS) is a rare, acute, immune-mediated polyneuropathy that affects the peripheral nerve system. It is characterized by progressive muscular weakness, areflexia, and, in severe cases, respiratory failure. This study thoroughly examines the pathophysiology, clinical manifestation, diagnostic criteria, current therapies, and prognosis of GBS. Early detection and appropriate treatment are essential for improving patient outcomes and minimizing issues. The peripheral nervous system is impacted by the uncommon, acute, immune-mediated polyneuropathy known as Guillain-Barré Syndrome (GBS). Progressive muscle weakening, areflexia, and, in extreme situations, respiratory failure are its hallmarks. The pathogenesis, clinical manifestation, diagnostic standards, available treatments, and prognosis of GBS are all thoroughly examined in this study. Reducing problems and enhancing patient outcomes require early detection and suitable treatment.